US2006280715A1PendingUtilityA1
Retinoid solutions and formulations made therefrom
Est. expiryMay 11, 2024(expired)· nominal 20-yr term from priority
A61K 9/12A61K 31/203A61K 47/10A61K 9/0014A61K 31/704A61K 47/24
61
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Compositions for topical application for treating a skin disorder (e.g., acne) include a retinoid, which is solubilized completely in alcohol only with the aid of cosolvents such as esters (e.g., alkyl benzoate, isopropyl palmitate, isopropyl myristate, diisopropyl adipate and their derivatives). This completely solubilized retinoid can be used to formulate an emulsion system or liquid to powder suspension containing a second active, such as an antibiotic (e.g., clindamycin).
Claims
exact text as granted — not AI-modified1 . A method of treating acne comprising applying to the skin of a subject afflicted with acne a composition comprising a solution, the solution comprising a retinoid, an anhydrous alcohol and an ester capable of solubilizing the retinoid in the presence of the anhydrous alcohol, wherein the amount of anhydrous alcohol is insufficient alone to solubilize the retinoid.
2 . A method as in claim 1 wherein the composition is an emulsion comprising an aqueous phase containing a water soluble active ingredient and a non-aqueous phase containing the solution.
3 . A method as in claim 1 wherein the composition is an emulsion comprising an aqueous phase containing clyndamycin, water and glycerine and a non-aqueous phase containing the solution.
4 . A method as in claim 1 wherein the composition is a suspension comprising a mixture of volatile silicone and starch and the solution.
5 . A method as in claim 1 wherein the composition is a suspension comprising a mixture of volatile silicone and starch, the solution and an aqueous phase containing clyndamycin, water, propylene glycol and glycerine.
6 . An apparatus comprising:
a first chamber containing a first composition, the first composition comprising a solution, the solution comprising retinoid, an anhydrous alcohol and an ester capable of solubilizing the retinoid in the presence of the anhydrous alcohol, wherein the amount of anhydrous alcohol is insufficient alone to solubilize the retinoid; a second chamber containing a second composition comprising an active ingredient selected from the group consisting of antibiotics; means for selectively interconnecting the first and second chambers to allow mixing of the first and second compositions; and at least one outlet for dispensing a mixture of the first and second compositions.Join the waitlist — get patent alerts
Track US2006280715A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.